Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIH-supported study pits BPH devices against drugs

This article was originally published in The Gray Sheet

Executive Summary

Medtronic and Urologix are among firms standing to benefit from a study comparing minimally invasive surgical treatment of benign prostatic hyperplasia (BPH) using transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to drugs. Efficacy of the devices, offered by such firms as Medtronic (TUNA) and Urologix (TUMT), first approved by FDA in 1996, will be compared to a regimen of finasteride (Proscar) and the alpha-1 inhibitor doxazosin (Cardura). The study will be run by The Minimally Invasive Surgical Therapies (MIST) Consortium, supported in part by both firms, and will be funded by $15 mil. from the National Institute of Diabetes & Digestive & Kidney Diseases at NIH. The protocol will include three-to-five-year follow-up, roughly through July 2009, on more than 700 men with moderate to severe symptoms...

You may also be interested in...

Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat

Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.

Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients

While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.

Medtech Industry Favorite Wins Seat On Powerful House E&C Committee

As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts